P-44 Impact of regorafenib dose optimization on clinical outcomes compared to best supportive care and TAS-102 in the treatment of relapsed/refractory metastatic colorectal cancer
| Autor: | T. Bekaii-Saab, H. Burnett, I. Proskorovsky, S. Yoon, Y. Wang, H. Ostojic, L. Gaianu, Y. Su |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Annals of Oncology. 33:S262 |
| ISSN: | 0923-7534 |
| DOI: | 10.1016/j.annonc.2022.04.135 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|